Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Horst Olschewski

Professor of Pulmonology and Experimental Medicine

Sigmund Freud PrivatUniversität Wien

Austria

Research Interests

Explore related searches

Professors in Austria

Articles (20)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Collaborators (14)

Andrew Sweatt

Assistant Professor- University Medical Line

Stanford University

UNITED STATES

View details

Valentina Biasin

Medical University of Graz

AUSTRIA

View details

Steven H. Abman

UNITED STATES

View details

Christophe GUIGNABERT

Director of Research (DR1) - Full Professor of Molecular Biology & Physiology

INSERM

FRANCE

View details

Konstantinos Kostikas

University of Ioannina

GREECE

View details

Jan Robert Kroeger

GERMANY

View details

Christian Gaebler

Associate Professor

Charité - Universitätsmedizin Berlin

GERMANY

View details

Rudolf E. Stauber

Medical University of Graz

AUSTRIA

View details

Edmund Lau

Clinical Professor

University of Sydney

AUSTRALIA

View details

Raphael W. Majeed

RWTH Aachen University

GERMANY

View details

Yuriy Sirenko

Head of Department, Professor

ukraine; shupyk national healthcare university of ukraine

UKRAINE

View details

Katarina Zeder

Medical University of Graz

AUSTRIA

View details

Christoph Magnes

Head of Research Group

Joanneum Research

AUSTRIA

View details

David Kiely

Director of Sheffield Pulmonary Vascular Disease Unit

University of Sheffield

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Horst Olschewski

Research Interests

Explore related searches

Articles (20)

Male survival disadvantage in pulmonary hypertension: independent of aetiology, age, disease severity, comorbidities and treatment

Pulmonary Artery and Vein Morphology as an Imaging Biomarker for the Diagnosis of Pulmonary Hypertension

Noninvasive mean pulmonary arterial pressure/oxygen uptake slope as a predictor of pulmonary exercise haemodynamics and outcome

Sotatercept Rescue Therapy for Acute Right Heart Failure in HIV‐Associated PAH

Prognostic Value of Exercise Testing in Patients with Liver Cirrhosis

Effect of aclidinium bromide therapy on quality of life and symptoms of patients with chronic obstructive pulmonary disease: pooled analysis results of the Greek and Austrian ON-AIR real-world observational studies

Functional characterization of KCNA5 gene variants linked to pulmonary arterial hypertension.

The Clinical Relevance of Unclassified Pulmonary Hypertension.

Update on pulmonary hypertension.

Detection of structural pulmonary changes with real-time high-fidelity analysis of expiratory CO2

Prognostic Relevance of Tricuspid Annular Plane Systolic Excursion to Systolic Pulmonary Arterial Pressure Ratio and Its Association With Exercise Hemodynamics in Patients With Normal or Mildly Elevated Resting Pulmonary Arterial Pressure

Significance of Pulmonary Vascular Dysfunction in Chronic Obstructive Pulmonary Disease

Hemodynamics and Phosphodiesterase-5 Inhibitor Treatment Associated with Survival in Pulmonary Hypertension in Interstitial Lung Disease A PVRI GoDeep Meta-Registry Analysis

Late Onset Pulmonary Arterial Hypertension Associated With Features of Pulmonary Veno‐Occlusive Disease and Rare Heterozygous Variants of KDR and EIF2AK4

Lipid Ratios for Diagnosis and Prognosis of Pulmonary Hypertension

IDO-1 Promotes Pulmonary Vascular Remodeling Via Kynurenine Pathway in Pulmonary Arterial Hypertension.

How It Really Happened‐the Development of Inhaled Iloprost for Pulmonary Arterial Hypertension

BK channels are indispensable for endothelial function in small pulmonary arteries.

Pathogenic SMAD6 variants in patients with idiopathic and complex congenital heart disease associated pulmonary arterial hypertension.

Phosphodiesterase-5 Inhibitor Treatment is Associated with Improved Survival in Pulmonary Hypertension Associated with COPD in the PVRI GoDeep Meta-Registry

Collaborators (14)

Andrew Sweatt

Valentina Biasin

Steven H. Abman

Christophe GUIGNABERT

Konstantinos Kostikas

Jan Robert Kroeger

Christian Gaebler

Rudolf E. Stauber

Edmund Lau

Raphael W. Majeed

Yuriy Sirenko

Katarina Zeder

Christoph Magnes

David Kiely

Make your next move.